SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050820
Filing Date
2020-11-05
Accepted
2020-11-05 06:32:59
Documents
64
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 KRTX-10-Q-20200930 krtx-10q_20200930.htm 10-Q 1994869
2 EX-31.1 krtx-ex311_6.htm EX-31.1 9448
3 EX-31.2 krtx-ex312_7.htm EX-31.2 9429
4 EX-32.1 krtx-ex321_8.htm EX-32.1 8514
  Complete submission text file 0001564590-20-050820.txt   6566489

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT krtx-20200930.xml EX-101.INS 1194819
6 XBRL TAXONOMY EXTENSION SCHEMA krtx-20200930.xsd EX-101.SCH 56254
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krtx-20200930_cal.xml EX-101.CAL 61419
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krtx-20200930_def.xml EX-101.DEF 194110
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20200930_lab.xml EX-101.LAB 421444
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20200930_pre.xml EX-101.PRE 327527
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38958 | Film No.: 201288534
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences